Eluxadoline (Viberzi) for Irritable Bowel Syndrome with Diarrhea

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2016年 / 58卷 / 1485期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [31] Radar plots: A novel modality for displaying disparate data on the efficacy of eluxadoline for the treatment of irritable bowel syndrome with diarrhea
    Brenner, D. M.
    Dove, L. S.
    Andrae, D. A.
    Covington, P. S.
    Gutman, C.
    Chey, W. D.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (08):
  • [32] Risk of Pancreatitis Following Treatment of Irritable Bowel Syndrome With Eluxadoline
    Gawron, Andrew J.
    Bielefeldt, Klaus
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (03) : 378 - +
  • [33] Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients With Irritable Bowel Syndrome With Diarrhea
    Harris, Lucinda
    Lucak, Susan
    Chang, Lin
    Dove, Leonard S.
    Covington, Paul S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S748 - S748
  • [34] Robustness of Eluxadoline for the Treatment of Irritable Bowel Syndrome With Diarrhea: Results From Phase 3 Composite Endpoint Assessments
    Lacy, Brian E.
    Dove, Scott
    Andrae, David
    Davenport, J. Michael
    Turner, Lisa
    Lopez, Rocio
    Covington, Paul S.
    GASTROENTEROLOGY, 2015, 148 (04) : S491 - S491
  • [35] Evaluating the safety and efficacy of eluxadoline for treating diarrhea-predominant irritable bowel syndrome: A Meta-analysis
    Shah, E.
    Schoenfeld, P.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 19 - 19
  • [36] Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study
    Priya Vijayvargiya
    Margaret Breen-Lyles
    Sara Linker Nord
    Daniel Maselli
    Irene Busciglio
    Ramesh Boinpally
    Anna Muslin
    Timothy J. Carrothers
    Michael Camilleri
    Digestive Diseases and Sciences, 2022, 67 : 3911 - 3921
  • [37] Constipation, diarrhea, and irritable bowel syndrome
    Browning, SM
    PRIMARY CARE, 1999, 26 (01): : 113 - +
  • [38] POSTVAGOTOMY DIARRHEA AND IRRITABLE BOWEL SYNDROME
    ROVATI, V
    FOSCHI, D
    RENDICONTI DI GASTRO-ENTEROLOGIA, 1975, 7 (02): : 140 - 140
  • [39] Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study
    Vijayvargiya, Priya
    Breen-Lyles, Margaret
    Nord, Sara Linker
    Maselli, Daniel
    Busciglio, Irene
    Boinpally, Ramesh
    Muslin, Anna
    Carrothers, Timothy J.
    Camilleri, Michael
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 3911 - 3921
  • [40] RIFAXIMIN AND ELUXADOLINE UTILIZATION FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) IN THE UNITED STATES AND BUDGET IMPACT ANALYSIS OF SWITCHING FROM ELUXADOLINE TO RIFAXIMIN
    Bloudek, L. M.
    Bozkaya, D.
    O'Hara, K.
    Kirby, S. K.
    Shah, S.
    VALUE IN HEALTH, 2018, 21 : S83 - S83
12345